绍兴贝斯美化工股份有限公司 关于 2023 年半年度募集资金存放与使用情况的专项报告 一、募集资金基本情况 （一）实际募集资金金额、资金到位时间 1、首次公开发行股票募集资金情况 经中国证券监督管理委员会证监发行字[2019]1783 号文核准，公司于 2019 年 11 月 向社会公开发行人民币普通股（A 股）3,030 万股，每股发行价为 14.25 元，应募集资金 总额为人民币 43,177.50 万元，根据有关规定扣除发行费用 3,879.74 万元后，实际募集 资金净额为 39,297.76 万元。该募集资金已于 2019 年 11 月到账。上述资金到账情况业 经容诚会计师事务所会验字[2019]7999 号《验资报告》验证。公司对募集资金采取了专 户存储管理。 2、向特定对象发行股票募集资金情况 经中国证券监督管理委员会《关于同意绍兴贝斯美化工股份有限公司向特定对象发 行股票注册的批复》（证监许可〔2021〕4023 号）同意，公司于 2022 年 4 月向特定对 象发行了人民币普通股（A 股）22,160,664 股，每股发行价为 18.05 元，募集资金总额 为人民币 399,999,985. ...

证券代码：300796 证券简称：贝斯美 公告编号：2023-031 绍兴贝斯美化工股份有限公司 第三届董事会第十二次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 一、 董事会会议召开情况 绍兴贝斯美化工股份有限公司（以下简称"公司"或"贝斯美"）第三届董事会第十二 次会议于2023年7月31日以专人送达或电话的形式通知各位董事、监事和高级管理人员,于 2023年8月10日上午9时在公司以现场结合通讯方式召开，会议由董事长陈峰先生主持，会议 应出席董事9人，实际出席董事9人，公司监事和高管列席了会议，本次会议的召集、召开、 表决程序符合《公司法》等法律法规和《公司章程》的规定。 二、 董事会会议审议情况 1、审议通过《关于公司2023年半年度报告全文及摘要的议案》。 董事会认为：公司《2023年半年度报告全文》及《2023年半年度报告摘要》的内容真实、 准确、完整地反映了公司2023年半年度经营的实际情况，不存在任何虚假记载、误导性陈述 或者重大遗漏；报告编制和审核的程序符合法律、行政法规的要求，符合中国证监会和深交 所的相关规定，同意对外报出 ...

一、开展远期外汇交易业务的目的 随着公司及子公司海外业务的发展，外币结算需求增加，汇率波动将对公司业绩产生 一定影响，鉴于目前外汇市场波动性增加，为尽力规避外汇市场的风险，减少未来外币兑 换人民币汇率波动对公司成本控制和经营业绩造成的不利影响，在保证日常营运资金需求 的情况下，公司拟开展远期外汇交易业务。 证券代码：300796 证券简称：贝斯美 公告编号：2023-033 绍兴贝斯美化工股份有限公司 关于开展远期外汇交易业务的公告 本公司及董事会全体成员保证公告的内容真实、准确和完整，没有虚假记载、误导性 陈述或重大遗漏。 绍兴贝斯美化工股份有限公司（以下简称"公司"）于2023年8月10日召开了第三届董事 会第十二次会议、第三届监事会第十二次会议，审议通过了《关于公司开展远期外汇交易业 务的议案》，同意公司及下属子公司根据实际经营需要开展远期外汇交易业务，并授权公司 管理层在额度范围内具体实施日常远期外汇交易业务。现将有关情况公告如下： 远期外汇交易是经中国人民银行批准的外汇避险金融产品。交易原理是：与银行签订 远期外汇交易协议，约定未来外汇交易的外汇币种、金额、期限及汇率，到期时按照该协 议订明的币种、 ...

中泰证券股份有限公司 关于绍兴贝斯美化工股份有限公司 部分募投项目延期的核查意见 中泰证券股份有限公司（以下简称"中泰证券"或"保荐机构"）作为绍兴贝斯 美化工股份有限公司（以下简称"公司"或"上市公司"）持续督导保荐机构，根据 《证券发行上市保荐业务管理办法》《深圳证券交易所创业板股票上市规则（2023 年修订）》以及《深圳证券交易所上市公司自律监管指引第 2 号——创业板上市 公司规范运作》等相关法律、法规和规范性文件的要求，对贝斯美本次部分募投 项目延期事项进行了核查，核查情况如下： 一、 向特定对象发行股票募集资金基本情况 经中国证券监督管理委员会《关于同意绍兴贝斯美化工股份有限公司向特定 对象发行股票注册的批复》（证监许可〔2021〕4023 号）同意，公司于 2022 年 4 月向特定对象发行了人民币普通股（A 股）22,160,664 股，每股发行价为 18.05 元，募集资金总额为人民币 399,999,985.20 元，扣除发行费用人民币 7,647,321.38 元（不含税）后，募集资金净额为人民币 392,352,663.82 元。2022 年 4 月 20 日， 中泰证券股份有限公司将 ...

公司法定代表人：陈峰 主管会计工作的负责人：屠汶君 会计机构负责人：屠汶君 | 编制单位：绍兴贝斯美化工股份有限公司 | | | | | | | | | 单位：元 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 非经营性资金占用 | 资金占用方名称 | 占用方与上市公司 | 上市公司核算的 | 2023年期初占用 | 2023年1-6月占用 | 2023年1-6月占用 | 2023年1-6月偿还 | 2023年6月末占用 | 占用形成原因 | 占用性质 | | | | 的关联关系 | 会计科目 | 资金余额 | 累计发生金额(不 含利息) | 资金的利息(如有) | 累计发生金额 | 资金余额 | | | | 控股股东、实际控制人及 | | | | | | | | | | | | 其附属企业 | | | | | | | | | | | | 小计 | | | | | | | | | | | | 前控股股东、实际控制人 | | | | | | | | | | | | 及其附属企业 | | | | | | | | | ...

证券代码：300796 证券简称：贝斯美 公告编号：2023-032 绍兴贝斯美化工股份有限公司 第三届监事会第十二次会议决议公告 本公司及监事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、监事会会议召开情况 绍兴贝斯美化工股份有限公司（以下简称"公司"）第三届监事会第十二次会议于 2023年8月10日下午13时在公司2楼会议室以现场方式召开。会议通知已于2023年7月31日 通过专人送出方式送达各位监事。本次会议应出席监事6人，实际出席监事6人。会议由监 事会主席董辉先生主持。会议的召开程序符合有关法律、法规、规章和《公司章程》的规定。 出席会议的监事对各项议案进行了认真审议并做出了如下决议： 二、 监事会会议审议情况 1、审议通过《关于公司2023年半年度报告全文及摘要的议案》。 监事会认为董事会编制和审核公司2023年半年度报告的程序符合法律、行政法规和中国 证监会的规定，报告内容真实、准确、完整地反映了公司的实际情况，不存在任何虚假记载、 误导性陈述或者重大遗漏。 《2023年半年度报告全文》及《2023年半年度报告摘要》具体内容详见公司披露于巨潮 资讯网（ ...

证券代码： 300796 证券简称：贝斯美 编号：2023-002 绍兴贝斯美化工股份有限公司 投资者关系活动记录表 | --- | --- | --- | |----------------|------------------------------------|------------------------------------------------------------| | 投资者关系活动 | 特定对象调研 | □ 分析师会议 | | 类别 | □ 媒体采访 | □ 业绩说明会 | | | □ 新闻发布会 □ | 路演活动 | | | 现场参观 | | | | □ 其他 | （请文字说明其他活动内容） | | 参与单位名称 | | 安信资管、财通基金、财通资管、东方证券、富安达基金、富国 | | | | 基金、广发基金、广发证券、国盛证券、国泰基金、华宝基金、 | | | | 汇丰晋信、华商基金、海通证券、华夏基金、恒越基金、杭银理 | | | | 财、嘉实基金、垒土资产、鹏华基金、浦银安盛、前海开源、睿 | | | | 郡资产、睿远基金、人保资产、申万菱信、天风证券、泰康基金、 | | | ...

Financial Performance - The company's revenue for Q1 2023 was ¥218,122,163.10, representing a 21.76% increase compared to ¥179,144,881.87 in the same period last year[5] - Net profit attributable to shareholders was ¥49,529,822.72, a significant increase of 60.07% from ¥30,943,310.64 in Q1 2022[5] - The net profit for the period was ¥51,050,512.43, a 60.56% increase from ¥31,795,374.38 in Q1 2022[11] - Total operating revenue for Q1 2023 was CNY 218,122,163.10, an increase of 21.7% compared to CNY 179,144,881.87 in Q1 2022[20] - Earnings per share for Q1 2023 were CNY 0.14, compared to CNY 0.10 in Q1 2022, reflecting a 40% increase[21] Cash Flow and Liquidity - The net cash flow from operating activities surged by 550.70%, reaching ¥90,637,544.38 compared to ¥13,929,328.09 in the previous year[5] - The cash inflow from operating activities totaled ¥224,426,954.24, an increase of 60.9% compared to ¥139,237,348.26 in the previous year[24] - The total cash flow from operating activities for Q1 2023 showed positive trends, indicating improved liquidity[22] - The total cash and cash equivalents at the end of the period were ¥594,485,431.48, down from ¥397,850,719.44 year-over-year[25] Assets and Liabilities - Total assets decreased by 1.56% to ¥2,067,885,173.00 from ¥2,100,743,391.28 at the end of the previous year[5] - Total liabilities as of Q1 2023 amounted to CNY 384,295,479.90, a decrease from CNY 469,242,056.36 in the previous year[22] - Total equity for Q1 2023 was CNY 1,683,589,693.10, up from CNY 1,631,501,334.92 in the same period last year[22] Expenses - Management expenses increased by 36.87% to ¥14,650,163.87, primarily due to higher startup costs for subsidiaries[10] - The company reported a 196.75% increase in income tax expenses, amounting to ¥15,737,616.94, reflecting higher profits[11] - Total operating costs for Q1 2023 were CNY 157,428,131.80, up 12.7% from CNY 139,680,471.75 in the same period last year[20] - Research and development expenses for Q1 2023 were CNY 9,227,900.39, slightly higher than CNY 9,111,939.15 in Q1 2022[20] Shareholder Information - Total number of common shareholders at the end of the reporting period is 8.991 million[13] - The largest shareholder, Ningbo Baismei Investment Holdings Co., Ltd., holds 23.02% of shares, totaling 46,177,211 shares[13] - The company has a total of 46,177,211 unrestricted shares held by the largest shareholder[14] Investment and Growth - The company is actively involved in the development of new products and technologies, although specific details were not disclosed in the report[16] - The company plans to continue expanding its market presence and investing in new technologies to drive future growth[22] Other Financial Metrics - Basic and diluted earnings per share increased by 40.00%, from ¥0.10 to ¥0.14[5] - Cash and cash equivalents at the end of the period increased by 49.42% to ¥594,485,431.48 from ¥397,850,719.44[11] - Accounts receivable decreased to ¥121,182,300.73 from ¥154,024,659.35, representing a decline of about 21.3%[17] - Inventory decreased to ¥72,781,193.73 from ¥89,087,205.39, a reduction of approximately 18.3%[17] - Non-current assets increased to ¥1,159,264,993.82 from ¥1,121,133,603.01, an increase of approximately 3.4%[17] Cash Flow Activities - The cash outflow for investing activities was ¥64,499,881.93, compared to ¥33,505,139.23 in the same period last year, resulting in a net cash flow from investing activities of -¥64,459,491.93[24] - The cash inflow from financing activities was ¥8,525,000.00, a decrease from ¥126,985,234.05 in the previous year[25] - The net cash flow from financing activities was -¥37,895,723.84, contrasting with a positive net cash flow of ¥93,860,495.24 in the same quarter last year[25] Audit Information - The company did not conduct an audit for the first quarter report[26]

证券代码： 300796 证券简称：贝斯美 编号：2023-001 绍兴贝斯美化工股份有限公司投资者关系活动记录表 感谢您的关注！ | 投资者关系活动 | □特定对象调研 □ 分析师会议 | | | --- | --- | --- | | 类别 | □ 媒体采访 √ 业绩说明会 | | | | □ 新闻发布会 □ 路演活动 | | | | 现场参观 □ | | | | 其他 （请文字说明其他活动内容） □ | | | 参与单位名称及 | 投资者网上提问 | | | 人员姓名 | | | | 时间 | 年 月 日 2023 3 (周五) 下午 15:00~17:00 | 17 | | 地点 | 公司通过全景网"投资者关系互动平台"（https://ir.p5w.net） | | | | 采用网络远程的方式召开业绩说明会 | | | 上市公司接待人 | 1、贝斯美董事长陈峰 | | | 员姓名 | 2、贝斯美董事、总经理钟锡君 | | | | 3、贝斯美财务总监屠汶君 | | | | 4、董事会秘书张校乾 | | | | 5、独立董事方咏梅 | | | | 6、保荐代表人戴菲 | | | 投资者关系活动 | 投资 ...

Financial Performance - The company's operating revenue for 2022 was ¥768,072,342.96, representing a 44.91% increase compared to ¥530,016,289.44 in 2021[24]. - Net profit attributable to shareholders for 2022 was ¥152,884,832.89, a significant increase of 171.10% from ¥56,393,722.60 in 2021[24]. - The net profit after deducting non-recurring gains and losses was ¥156,414,033.56, up 171.15% from ¥57,684,802.87 in the previous year[24]. - The total assets at the end of 2022 reached ¥2,100,743,391.28, marking a 50.25% increase from ¥1,398,208,062.65 at the end of 2021[24]. - The basic earnings per share for 2022 was ¥0.79, reflecting a 132.35% increase compared to ¥0.34 in 2021[24]. - The cash flow from operating activities for 2022 was ¥186,518,934.28, which is a 95.01% increase from ¥95,647,029.55 in 2021[24]. - The company reported a quarterly revenue of ¥221,591,607.95 in Q4 2022, the highest among the four quarters[26]. - In 2022, the company achieved a sales revenue of 768 million yuan, representing a year-on-year increase of 45%[64]. - The net profit attributable to shareholders reached 153 million yuan, a significant year-on-year growth of 171%[64]. - The revenue from the main product, dimethyl sulfoxide (DMS), was ¥614,612,307.50, accounting for 80.02% of total revenue, with a year-on-year growth of 54.01%[72]. - Revenue from international markets was ¥490,503,771.32, representing 63.86% of total revenue, with a significant increase of 72.72% compared to ¥283,990,257.00 in 2021[72]. - Direct sales accounted for 97.44% of total revenue at ¥748,447,564.97, showing a year-on-year increase of 57.60%[72]. - Gross profit margin for the main product DMS was 40.15%, up from 32.71% in the previous year, indicating improved profitability[75]. - The sales volume of DMS increased by 20.47% to 11,020.49 tons in 2022, compared to 9,147.77 tons in 2021[77]. Dividend and Shareholder Information - The company plans to distribute a cash dividend of 1.2 CNY per 10 shares to all shareholders, based on a total of 200,634,929 shares[3]. - The company held three temporary shareholder meetings in 2022, with investor participation rates of 49.98%, 42.24%, and 41.40% respectively[163]. - The annual shareholder meeting in 2021 had a participation rate of 49.97%[163]. - The company reported a total of 536,900 shares held by directors at the end of the reporting period, with an increase of 153,400 shares during the period[166]. Risk Management - The company faces several risks including market growth below expectations, high customer concentration, and fluctuations in tax incentives and exchange rates[3]. - The company emphasizes the importance of risk awareness among investors regarding forward-looking statements and future plans[3]. - The company has detailed its future development outlook and risk management strategies in the management discussion section of the report[3]. Research and Development - The company is actively enhancing its R&D capabilities to address the need for optimization in domestic pesticide production processes[43]. - The company holds 53 authorized patents, including 23 invention patents and 30 utility model patents, reflecting its strong R&D capabilities[56]. - The company is currently developing new pesticide varieties and carbon five new material products, laying a solid foundation for future growth[56]. - The company is focused on integrating its operations across the entire industrial chain, enhancing its overall competitiveness compared to single-segment pesticide manufacturers[55]. - The company has established partnerships with universities and research institutions to enhance its R&D efforts[56]. - The company is developing new products and technologies, including the synthesis of herbicide intermediates and optimization of existing processes to enhance market competitiveness[86]. Market and Industry Trends - The global crop protection market is projected to reach $66.703 billion in 2023, with a compound annual growth rate of 3% from 2018 to 2023[36]. - The company operates in a highly concentrated global pesticide market, which is expected to provide growth opportunities for leading raw material enterprises[37]. - The domestic pesticide industry is undergoing significant transformation, with a strong demand for green pesticides and a rapid phase-out of high-toxicity products[41]. - The pesticide market is shifting towards high-efficiency, low-toxicity, and low-residue products, driven by stricter environmental regulations[41]. - The global pesticide market sales increased from $25.15 billion in 2002 to $62.04 billion in 2020, indicating a growing market[127]. - By 2030, the global population is expected to reach 8.5 billion, increasing the demand for food and consequently for pesticides[128]. Corporate Governance - The company strictly adheres to laws and regulations, ensuring compliance with corporate governance standards as of the end of the reporting period[147]. - The board of directors consists of 9 members, including 3 independent directors, meeting legal requirements[149]. - The company has established a compensation mechanism linking salaries to company performance and individual achievements to attract and retain talent[152]. - The company maintains complete independence in operations, assets, and financial matters from its controlling shareholders and related parties[156]. - The company has a fully independent financial accounting department, capable of making independent financial decisions[162]. - The company has a governance structure that includes a mix of independent and non-independent directors[165]. - The company has a total of 10 directors and supervisors, with 6 receiving remuneration from the company[186]. Environmental and Safety Management - The company emphasizes green and environmentally friendly production processes, aiming to reduce waste emissions while increasing output[56]. - The company has a valid safety production license until July 16, 2024[50]. - The company is actively applying for and obtaining environmental impact assessments for new projects[49]. - The company has a valid pollutant discharge permit until December 31, 2025[50]. - The company will continue to enhance safety and environmental management to ensure stable and orderly production operations[142]. Employee and Talent Management - The company has established a performance-based compensation system that includes basic salary, performance bonuses, allowances, and overtime pay[199]. - The company will continue to improve its compensation system to enhance employee recognition and belonging, ensuring a talent pool for long-term development[199]. - In 2023, the company will focus on targeted, effective, and practical training to improve management skills and employee competencies[200]. - The company’s management team includes a diverse group of individuals with varying ages and backgrounds[165]. - The company has a total of 492 employees at the end of the reporting period, with 208 in the parent company and 284 in major subsidiaries[197].